Firefly Neuroscience (AIFF) Change in Accured Expenses (2010 - 2026)

Firefly Neuroscience has reported Change in Accured Expenses for 17 years, with the latest figure at $71000.0 in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 109.94% year-over-year to $71000.0 in Q2 2026; TTM through Jun 2026 was -$10000.0, a 99.66% increase from a year earlier, with the FY2025 full-year figure at -$952000.0, down 179.18% from the prior year.
• Change in Accured Expenses was $71000.0 for Q2 2026 at Firefly Neuroscience, up from -$313000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $943000.0 in Q4 2023, with the low at -$929000.0 in Q2 2024.
• Average Change in Accured Expenses over 5 years is -$132808.3, with a median of $16672.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses soared 2793.37% in 2022, then plunged 4021.57% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$418527.0 in 2022, then surged by 325.31% to $943000.0 in 2023, then tumbled by 186.32% to -$814000.0 in 2024, then surged by 113.02% to $106000.0 in 2025, then tumbled by 33.02% to $71000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $71000.0 (Q2 2026), -$313000.0 (Q1 2026), and $106000.0 (Q4 2025), per Business Quant data.